|Articles|March 23, 2020

PsychPearls: Battling Loneliness During the COVID-19 Pandemic

What can psychiatrists do to help their patients cope with self-quarantine and isolation practices? More in this podcast.

We have invited Dr Joshua Morganstein, Chair of the American Psychiatric Association Committee on the Psychiatric Dimensions of Disaster, to provide suggestions about helping patients cope with social distancing and loneliness.

What can psychiatrists do to help their patients cope with self-quarantine and isolation practices?

Have more COVID concerns and clinical tips? Email us at PTEditor@mmhgroup.com. We may share your stories, queries, or thoughts in a future editorial or even as a standalone piece. Check out our COVID-19 Resource Page for Psychiatrists.

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related to this article

September 22nd, 2026

New Preliminary Positive Data From Open-Label Extension of Phase 3 Study: Fasedienol for the Acute Treatment of Social Anxiety Disorder

Open-label extension data show fasedienol appears well tolerated and steadily improves social anxiety scores with as-needed intranasal use, as Vistagen plans FDA discussions.

September 18th, 2026

Centanafadine For Comorbid ADHD and Anxiety: Talking New Data With John Kraus, MD, PhD

Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.

PsychPearls: Battling Loneliness During the COVID-19 Pandemic

Related to this article

Trending on Psychiatric Times

ACNP Position Paper Lays Out Roadmap for Biomarker-Guided Psychiatric Drug Trials

Real-World Data Link LAI Risperidone to Fewer Emergency Visits in Schizophrenia, Improved Bipolar Treatment

From Side Effect to Target: Rethinking Metabolic Dysfunction in Psychiatry

Nature vs Nurture: The Interplay Between Genetics and Environmental Influences

Post Hoc SOLARIS Data Support Stabilization and Remission With Subcutaneous Olanzapine